Renovatio Clinical — Houston, Texas

Renovatio Clinical is a clinical research site located in Houston, Texas, United States 77380.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Renovatio Clinical has participated in 9 clinical trials.

Therapeutic areas: Alpha 1-Antitrypsin Deficiency, Metastatic Breast Cancer, Alpha1-Antitrypsin Deficiency.

Sponsors: Vertex Pharmaceuticals Incorporated, Eli Lilly and Company, Suzhou Kintor Pharmaceutical Inc,.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Renovatio Clinical?

Renovatio Clinical has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Renovatio Clinical conducted?

Renovatio Clinical has 9 clinical trials on record. Their work covers Alpha 1-Antitrypsin Deficiency, Metastatic Breast Cancer, Alpha1-Antitrypsin Deficiency.

Is Renovatio Clinical accredited by Crixeo Health?

Yes — Renovatio Clinical holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Renovatio Clinical?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.